Q4 2025 · 13F-HR
ALLEN HOLDING INC /NYholdings as filed
Filed 2026-02-10 · accession 0001214659-26-001412
$1.05B
Reported value
9
Positions
2025-12-31
Period end
The Brief · ALLEN HOLDING INC /NY · Q4 2025
AI · grounded in 13F
ALLEN HOLDING INC /NY trimmed its position in PLTR by 5.88%. The fund also reduced its holding in BRK/A by 3.94%. These were the only two positions reduced among the fund's 9 total holdings. Total assets under management stood at $1.05B.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 191216100 | KO | COCA COLA CO | $419.5M | 40.0% | 6,000,000 | Common | SOLE |
| 69608A108 | PLTR | PALANTIR TECHNOLOGIES INC | $284.4M | 27.1% | 1,600,000 | Common | SOLE |
| 084670108 | BRK/A | BERKSHIRE HATHAWAY INC DEL | $239.3M | 22.8% | 317 | Common | SOLE |
| 717081103 | PFE | PFIZER INC | $37.8M | 3.61% | 1,519,800 | Common | SOLE |
| 44891N208 | IAC | IAC INC | $23.5M | 2.24% | 601,100 | Common | SOLE |
| 00827B106 | AFRM | AFFIRM HLDGS INC | $17.1M | 1.63% | 230,000 | Common | SOLE |
| 060505104 | BAC | BANK AMERICA CORP | $16.5M | 1.57% | 300,000 | Common | SOLE |
| 46625H100 | JPM | JPMORGAN CHASE & CO. | $9.7M | 0.92% | 30,000 | Common | SOLE |
| 45256X103 | IBRX | IMMUNITYBIO INC | $1.4M | 0.13% | 687,571 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.